article thumbnail

Why demand is rising for secure and climate-controlled gene therapy services

Pharmaceutical Technology

“Cell and gene therapies are not your typical clinical supply chain. It’s much more complex and it has to be 100% correct, or else patients are really at risk,” explains Michael MacNeir, vice president of Business Development, Sharp Clinical. The requirements When handling personalised medicines, time is of the essence.

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial.